These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 6351580)

  • 1. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
    Firth BG; Winniford MD; Campbell WB; Hillis LD
    Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostacyclin on coronary hemodynamics at rest and in response to cold pressor testing in patients with angina pectoris.
    Ganz P; Gaspar J; Colucci WS; Barry WH; Mudge GH; Alexander RW
    Am J Cardiol; 1984 Jun; 53(11):1500-4. PubMed ID: 6375336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
    Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
    Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin therapy in patients with congestive heart failure.
    Yui Y; Nakajima H; Kawai C; Murakami T
    Am J Cardiol; 1982 Aug; 50(2):320-4. PubMed ID: 7048886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris.
    Ikram H; Low CJ; Shirlaw T; Webb CM; Richards AM; Crozier IG
    Am J Cardiol; 1990 Jul; 66(2):164-7. PubMed ID: 2196774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats.
    Quyyumi AA; Iaffaldano R; Guerrero JL; Ryan CA; Powell WJ; Axelrod L
    Diabetes; 1989 Dec; 38(12):1585-94. PubMed ID: 2511053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute hemodynamic effects of prostacyclin in severe or malignant hypertension].
    Chaignon M; Tannière-Ruffie ML; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():147-50. PubMed ID: 6810818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of prostacyclin on hemodynamic and coronary blood flow in dogs.
    Teesalu R; Kòrgevee A
    Biomed Biochim Acta; 1988; 47(10-11):S56-9. PubMed ID: 3073770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that prostacyclin modulates the vascular actions of calcium in man.
    Nadler JL; McKay M; Campese V; Vrbanac J; Horton R
    J Clin Invest; 1986 Apr; 77(4):1278-84. PubMed ID: 3514678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous prostacyclin in variant angina.
    Chierchia S; Patrono C; Crea F; Ciabattoni G; De Caterina R; Cinotti GA; Distante A; Maseri A
    Circulation; 1982 Mar; 65(3):470-7. PubMed ID: 7034990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease.
    Bergman G; Daly K; Atkinson L; Rothman M; Richardson PJ; Jackson G; Jewitt DE
    Lancet; 1981 Mar; 1(8220 Pt 1):569-72. PubMed ID: 6110816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of norepinephrine infusion on systemic hemodynamics and plasma 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension.
    Ishii M; Uehara Y; Hirata Y; Atarashi K; Ikeda T; Sugimoto T; Takeda T; Murao S
    Jpn Circ J; 1982 May; 46(5):494-502. PubMed ID: 7043017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
    J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2.
    Cuiper LL; Price PV; Christman BW
    J Appl Physiol (1985); 1996 Jan; 80(1):191-7. PubMed ID: 8847301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prostacyclin on systemic and coronary hemodynamics in the dog.
    Mehta J; Nichols WW; Mehta P; Pepine C; Conti CR
    Am Heart J; 1981 Nov; 102(5):835-40. PubMed ID: 7030040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary effects of prostacyclin infusion in anesthetized horses.
    Trim CM; Moore JN; Hardee MM; Hardee GE; Graham DA
    Am J Vet Res; 1985 Apr; 46(4):928-31. PubMed ID: 3893242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic responses to prostacyclin (PGI2) in the conscious sheep.
    Kubo K; Kobayashi T; Yoshimura K; Fukushima M; Handa K; Kusama S; Sakai A; Ueda G
    Jpn Circ J; 1982 Dec; 46(12):1292-304. PubMed ID: 6754986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.